These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28736835)

  • 1. Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.
    Heineke MH; van der Steen LPE; Korthouwer RM; Hage JJ; Langedijk JPM; Benschop JJ; Bakema JE; Slootstra JW; van Egmond M
    Eur J Immunol; 2017 Oct; 47(10):1835-1845. PubMed ID: 28736835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
    Aleyd E; Heineke MH; van Egmond M
    Immunol Rev; 2015 Nov; 268(1):123-38. PubMed ID: 26497517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4.
    van der Steen L; Tuk CW; Bakema JE; Kooij G; Reijerkerk A; Vidarsson G; Bouma G; Kraal G; de Vries HE; Beelen RH; van Egmond M
    Gastroenterology; 2009 Dec; 137(6):2018-29.e1-3. PubMed ID: 19555692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA Complexes in Plasma and Synovial Fluid of Patients with Rheumatoid Arthritis Induce Neutrophil Extracellular Traps via FcαRI.
    Aleyd E; Al M; Tuk CW; van der Laken CJ; van Egmond M
    J Immunol; 2016 Dec; 197(12):4552-4559. PubMed ID: 27913645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.
    Breedveld A; van Egmond M
    Front Immunol; 2019; 10():553. PubMed ID: 30984170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FcαRI binding at the IgA1 C
    Posgai MT; Tonddast-Navaei S; Jayasinghe M; Ibrahim GM; Stan G; Herr AB
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8882-E8891. PubMed ID: 30181292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin A: magic bullet or Trojan horse?
    Heineke MH; van Egmond M
    Eur J Clin Invest; 2017 Feb; 47(2):184-192. PubMed ID: 28024097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
    Herr AB; Ballister ER; Bjorkman PJ
    Nature; 2003 Jun; 423(6940):614-20. PubMed ID: 12768205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking Fcα receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies.
    van der Steen LP; Bakema JE; Sesarman A; Florea F; Tuk CW; Kirtschig G; Hage JJ; Sitaru C; van Egmond M
    J Immunol; 2012 Aug; 189(4):1594-601. PubMed ID: 22802416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity.
    van Delft MAM; Aleyd E; van der Mast R; de Jong N; Boon L; Simons PJ; van Egmond M
    Front Immunol; 2023; 14():1118539. PubMed ID: 37081893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironment.
    Wehrli M; Cortinas-Elizondo F; Hlushchuk R; Daudel F; Villiger PM; Miescher S; Zuercher AW; Djonov V; Simon HU; von Gunten S
    J Immunol; 2014 Dec; 193(11):5649-59. PubMed ID: 25339672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA Fc receptors.
    Monteiro RC; Van De Winkel JG
    Annu Rev Immunol; 2003; 21():177-204. PubMed ID: 12524384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
    Valerius T; Stockmeyer B; van Spriel AB; Graziano RF; van den Herik-Oudijk IE; Repp R; Deo YM; Lund J; Kalden JR; Gramatzki M; van de Winkel JG
    Blood; 1997 Dec; 90(11):4485-92. PubMed ID: 9373259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalent binding of IgA1 to FcalphaRI suggests a mechanism for cytokine activation of IgA phagocytosis.
    Herr AB; White CL; Milburn C; Wu C; Bjorkman PJ
    J Mol Biol; 2003 Mar; 327(3):645-57. PubMed ID: 12634059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA.
    Wu J; Ji C; Xie F; Langefeld CD; Qian K; Gibson AW; Edberg JC; Kimberly RP
    J Immunol; 2007 Mar; 178(6):3973-82. PubMed ID: 17339498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
    Ben Mkaddem S; Rossato E; Heming N; Monteiro RC
    Autoimmun Rev; 2013 Apr; 12(6):666-9. PubMed ID: 23201915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-FcαRI Monoclonal Antibodies Resolve IgA Autoantibody-Mediated Disease.
    Bos A; Aleyd E; van der Steen LPE; Winter PJ; Heemskerk N; Pouw SM; Boon L; Musters RJP; Bakema JE; Sitaru C; Cogné M; van Egmond M
    Front Immunol; 2022; 13():732977. PubMed ID: 35371001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin A-mediated protection against Bordetella pertussis infection.
    Hellwig SM; van Spriel AB; Schellekens JF; Mooi FR; van de Winkel JG
    Infect Immun; 2001 Aug; 69(8):4846-50. PubMed ID: 11447159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin-binding sites of human FcalphaRI (CD89) and bovine Fcgamma2R are located in their membrane-distal extracellular domains.
    Morton HC; van Zandbergen G; van Kooten C; Howard CJ; van de Winkel JG; Brandtzaeg P
    J Exp Med; 1999 Jun; 189(11):1715-22. PubMed ID: 10359575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal capsular polysaccharide-specific IgA triggers efficient neutrophil effector functions via FcalphaRI (CD89).
    van der Pol W; Vidarsson G; Vilé HA; van de Winkel JG; Rodriguez ME
    J Infect Dis; 2000 Oct; 182(4):1139-45. PubMed ID: 10979910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.